Collectively, this study provides proof‐of‐concept evidence that overexpression of the cancer suppressor gene SHISA3 in TAMs enhanced the innate and adaptive immune responses to tumor cells thus reshaping the immunosuppressive TME (Figure S9, Supporting Information), and would shed light on the development of new therapeutics for cancer immunotherapy. The gene discussed is SHISA3; the disease is neoplasm.